Skip to content

Clinical and Dynamic Floor MRI Evaluation Before and After Prolapse Surgery

Pre- and Postoperative Dynamic Floor MRI in Order to Evaluate the Anatomical and Functional Changes of the Different Pelvic Floor Organs, Before and After Prolapse Surgery.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03400007
Enrollment
34
Registered
2018-01-17
Start date
2017-11-01
Completion date
2021-10-26
Last updated
2022-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prolapse

Keywords

dynamic floor magnetic resonance imaging, colpocystodefecagraphy, prolapse surgery

Brief summary

Pelvic organ prolapsed, associated with defecation disorders and urinary tracts symptoms are common and affect up to 25% of the population, mostly parous women. The pelvic floor must be seen as one entity, with multiple anatomical and physiological interactions between the various compartments (rectum, vagina, uterus and bladder) which are embedded in the same anatomical region. The often complex pathologies of this region should therefore be treated in a multidisciplinary setting. Besides clinical evaluation, functional dynamic imaging of anorectal and pelvic floor disfunctions has an important role in the diagnosis and management of these disorders. Although the colpocystodefecography is still considered to be the golden standard in imaging this complex anatomical region, there is clearly a need for more precise imaging of the structural details, preferentially without any irradiation. Transperineal ultrasound is an option but the investigators have chosen to evaluate the use of dynamic magnetic resonance imaging. In contrast to colpocystodefecography, dynamic pelvic floor magnetic resonance imaging is an evolving technology and its precise role in functional imaging of the pelvic floor still remains to be determined. Prolapse surgery is commonly performed and therefore it is important to assess the efficacy of the operations in correcting the anatomical defects and the symptoms associated without creating new, pelvic floor related symptoms. Few studies exist today allowing the assessment of the anatomical changes and symptoms after surgery, through abdominal or perineal approach. This study will evaluate the reliability of the dynamic pelvic floor imaging, done in a sitting position, compared to colpocystodefecography, done in a sitting position. It will also compare clinical objective and subjective results related to pelvic floor abnormalities with imaging. Finally, it will evaluate the anatomical changes in correlation with the clinical results, organ position and inter-compartments relationships after surgery. This study will allow to understand and explain some relapses and failures and could lead to an improvement of the indications for surgery and surgical techniques used.

Interventions

DEVICEDynamic floor magnetic resonance imaging

Dynamic floor magnetic resonance imaging (MRI)

DEVICEColpocystodefecography

Colpocystodefecography (CCD)

Sponsors

Tatiana Besse-Hammer
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

All patients who will undergo internal or external rectal prolapse, enterocele or urogenital prolapse surgery in CHU Brugmann and CHU St Pierre.

Exclusion criteria

* MRI contra-indications * Patients with prior pelvic floor surgery

Design outcomes

Primary

MeasureTime frameDescription
Dynamic MRI: medium compartment6 months post surgeryVagina horizontalization (yes/no)
recto-anal angle -relax position6 months post surgeryMeasured by dynamic floor MRI in left lateral decubitus position (141°)
recto-anal angle -retain position6 months post surgeryMeasured by dynamic floor MRI in left lateral decubitus position (163°)
recto-anal angle -push position6 months post surgeryMeasured by dynamic floor MRI in left lateral decubitus position (165°)
Dynamic MRI: anterior compartment6 months post surgeryFrom the bladder, discrete inferior descent of the pubococcygeal line: max 1/3 (yes/no)

Secondary

MeasureTime frameDescription
Fecal Incontinence Severity Index (FISI)6 months post surgeryThis is a health tool that describes the severity of different types of incontinence for bowel contents.There are 4 items in the FISI scale with 6 answer choices. Points are awarded according to the gravity of the symptoms. The higher the FISI index (which ranges from 0 to 61), the higher the severity of the fecal incontinence.
Constipation scoring system (CCS)6 months post surgeryValidated questionnaire. Minimum Score, 0 - Maximum Score, 30
Prolapse Quality of Life (P-QOL) questionnaire6 months post surgeryValidated questionnaire covering nine domains: general health (1 item), prolapse impact (1 item), role (2 items), physical (2 items) and social limitations (3 items), personal relationships (2 items), emotions (3 items), sleep/energy (2 items), and severity measurement (4 items). The answers are categorized using a fourpoint Likert scale: none/not at all, slightly/a little, moderately, and a lot. A score is calculated for each domain ranging from 0 to 100. A higher score indicates a greater impairment of quality of life.
Sexual function questionnaire (PISQ-IR)6 months post surgeryValidated questionnaire. The PISQ-12 measures three domains: behavioral-emotive (items 1 - 4), physical (items 5 - 9) and partner-related (items 10 - 12). It is a self-administered questionnaire, and responses are graded on a five-point Likert scale ranging from 0 (always) to 4 (never). Items 1 - 4 are reversely scored and a total of 48 is the maximum score. Higher scores indicate better sexual function.
Visual analogic Scale (VAS)6 months post surgeryThe VAS scale (EVA in French) is a straight line of 100 mn length. One end is the absence of pain, the other end represents unbearable pain. The patient places a mark between these 2 extremities according to the intensity of his pain at a given time.

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026